263 related articles for article (PubMed ID: 14960512)
1. An interleukin 12 p40-IgG2b fusion protein abrogates T cell mediated inflammation: anti-inflammatory activity in Crohn's disease and experimental colitis in vivo.
Stallmach A; Marth T; Weiss B; Wittig BM; Hombach A; Schmidt C; Neurath M; Zeitz M; Zeuzem S; Abken H
Gut; 2004 Mar; 53(3):339-45. PubMed ID: 14960512
[TBL] [Abstract][Full Text] [Related]
2. Mycophenolate Mofetil Modulates Differentiation of Th1/Th2 and the Secretion of Cytokines in an Active Crohn's Disease Mouse Model.
Lv QK; Liu JX; Li SN; Gao YJ; Lv Y; Xu ZP; Huang BX; Xu SY; Yang DX; Zeng YL; Liu DF; Wang W
Int J Mol Sci; 2015 Nov; 16(11):26654-66. PubMed ID: 26561804
[TBL] [Abstract][Full Text] [Related]
3. Protection of trinitrobenzene sulfonic acid-induced colitis by an interleukin 2-IgG2b fusion protein in mice.
Stallmach A; Wittig B; Giese T; Pfister K; Hoffmann JC; Bulfone-Paus S; Kunzendorf U; Meuer SC; Zeitz M
Gastroenterology; 1999 Oct; 117(4):866-76. PubMed ID: 10500069
[TBL] [Abstract][Full Text] [Related]
4. Involvement of interleukin 18 in Crohn's disease: evidence from in vitro analysis of human gut inflammatory cells and from experimental colitis models.
Maerten P; Shen C; Colpaert S; Liu Z; Bullens DA; van Assche G; Penninckx F; Geboes K; Vanham G; Rutgeerts P; Ceuppens JL
Clin Exp Immunol; 2004 Feb; 135(2):310-7. PubMed ID: 14738461
[TBL] [Abstract][Full Text] [Related]
5. Cholera toxin subunit B inhibits IL-12 and IFN-{gamma} production and signaling in experimental colitis and Crohn's disease.
Coccia EM; Remoli ME; Di Giacinto C; Del Zotto B; Giacomini E; Monteleone G; Boirivant M
Gut; 2005 Nov; 54(11):1558-64. PubMed ID: 16105891
[TBL] [Abstract][Full Text] [Related]
6. Both IL-12p70 and IL-23 are synthesized during active Crohn's disease and are down-regulated by treatment with anti-IL-12 p40 monoclonal antibody.
Fuss IJ; Becker C; Yang Z; Groden C; Hornung RL; Heller F; Neurath MF; Strober W; Mannon PJ
Inflamm Bowel Dis; 2006 Jan; 12(1):9-15. PubMed ID: 16374252
[TBL] [Abstract][Full Text] [Related]
7. Development of recombinant vaccines against IL-12/IL-23 p40 and in vivo evaluation of their effects in the downregulation of intestinal inflammation in murine colitis.
Guan Q; Ma Y; Hillman CL; Ma A; Zhou G; Qing G; Peng Z
Vaccine; 2009 Nov; 27(50):7096-104. PubMed ID: 19786142
[TBL] [Abstract][Full Text] [Related]
8. Contrasting roles of IL-12p40 and IL-12p35 in the development of hapten-induced colitis.
Camoglio L; Juffermans NP; Peppelenbosch M; te Velde AA; ten Kate FJ; van Deventer SJ; Kopf M
Eur J Immunol; 2002 Jan; 32(1):261-9. PubMed ID: 11782017
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to interleukin 12 abrogate established experimental colitis in mice.
Neurath MF; Fuss I; Kelsall BL; Stüber E; Strober W
J Exp Med; 1995 Nov; 182(5):1281-90. PubMed ID: 7595199
[TBL] [Abstract][Full Text] [Related]
10. Oral administration of recombinant cholera toxin subunit B inhibits IL-12-mediated murine experimental (trinitrobenzene sulfonic acid) colitis.
Boirivant M; Fuss IJ; Ferroni L; De Pascale M; Strober W
J Immunol; 2001 Mar; 166(5):3522-32. PubMed ID: 11207312
[TBL] [Abstract][Full Text] [Related]
11. RDP58, a novel immunomodulatory peptide with anti-inflammatory effects. A pharmacological study in trinitrobenzene sulphonic acid colitis and Crohn disease.
Bourreille A; Doubremelle M; de la Blétière DR; Segain JP; Toquet C; Buelow R; Galmiche JP
Scand J Gastroenterol; 2003 May; 38(5):526-32. PubMed ID: 12795464
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 16 is up-regulated in Crohn's disease and participates in TNBS colitis in mice.
Keates AC; Castagliuolo I; Cruickshank WW; Qiu B; Arseneau KO; Brazer W; Kelly CP
Gastroenterology; 2000 Oct; 119(4):972-82. PubMed ID: 11040184
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-12 antagonists as new therapeutic agents in inflammatory bowel disease.
Schmidt C; Marth T; Wittig BM; Hombach A; Abken H; Stallmach A
Pathobiology; 2002-2003; 70(3):177-83. PubMed ID: 12571423
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of the IL-12 receptor beta 2 chain in Crohn's disease.
Parrello T; Monteleone G; Cucchiara S; Monteleone I; Sebkova L; Doldo P; Luzza F; Pallone F
J Immunol; 2000 Dec; 165(12):7234-9. PubMed ID: 11120856
[TBL] [Abstract][Full Text] [Related]
15. Evidence for the critical role of interleukin-12 but not interferon-gamma in the pathogenesis of experimental colitis in mice.
Tozawa K; Hanai H; Sugimoto K; Baba S; Sugimura H; Aoshi T; Uchijima M; Nagata T; Koide Y
J Gastroenterol Hepatol; 2003 May; 18(5):578-87. PubMed ID: 12702051
[TBL] [Abstract][Full Text] [Related]
16. Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-gamma and TNF-alpha production.
Siegmund B; Fantuzzi G; Rieder F; Gamboni-Robertson F; Lehr HA; Hartmann G; Dinarello CA; Endres S; Eigler A
Am J Physiol Regul Integr Comp Physiol; 2001 Oct; 281(4):R1264-73. PubMed ID: 11557635
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease.
Abad C; Martinez C; Juarranz MG; Arranz A; Leceta J; Delgado M; Gomariz RP
Gastroenterology; 2003 Apr; 124(4):961-71. PubMed ID: 12671893
[TBL] [Abstract][Full Text] [Related]
18. Targeting IL-12/IL-23 by employing a p40 peptide-based vaccine ameliorates TNBS-induced acute and chronic murine colitis.
Guan Q; Ma Y; Hillman CL; Qing G; Ma AG; Weiss CR; Zhou G; Bai A; Warrington RJ; Bernstein CN; Peng Z
Mol Med; 2011; 17(7-8):646-56. PubMed ID: 21424108
[TBL] [Abstract][Full Text] [Related]
19. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease.
Reinecker HC; Steffen M; Witthoeft T; Pflueger I; Schreiber S; MacDermott RP; Raedler A
Clin Exp Immunol; 1993 Oct; 94(1):174-81. PubMed ID: 8403503
[TBL] [Abstract][Full Text] [Related]
20. Chlorophyllin attenuates IFN-gamma expression in lipopolysaccharide-stimulated murine splenic mononuclear cells via suppressing IL-12 production.
Yun CH; Son CG; Chung DK; Han SH
Int Immunopharmacol; 2005 Dec; 5(13-14):1926-35. PubMed ID: 16275627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
